LTIP491A - Hydroxyquinolone derivatives - Google Patents
Hydroxyquinolone derivativesInfo
- Publication number
- LTIP491A LTIP491A LTIP491A LTIP491A LTIP491A LT IP491 A LTIP491 A LT IP491A LT IP491 A LTIP491 A LT IP491A LT IP491 A LTIP491 A LT IP491A LT IP491 A LTIP491 A LT IP491A
- Authority
- LT
- Lithuania
- Prior art keywords
- derivatives
- hydroxyquinolone
- nmda
- antagonists
- receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
A class of 4-hydroxy-2-(1H)-quinolone derivatives, substituted at the 3-position by an optionally substituted aryl substituent, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA receptor antagonist.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909022785A GB9022785D0 (en) | 1990-10-19 | 1990-10-19 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP491A true LTIP491A (en) | 1994-11-25 |
LT3305B LT3305B (en) | 1995-06-26 |
Family
ID=10684029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP491A LT3305B (en) | 1990-10-19 | 1993-04-19 | Hydroxyquinolone derivatives |
Country Status (9)
Country | Link |
---|---|
US (2) | US5348962A (en) |
EP (1) | EP0481676B1 (en) |
JP (1) | JPH0780853B2 (en) |
AT (1) | ATE148458T1 (en) |
CA (1) | CA2053465A1 (en) |
DE (1) | DE69124454T2 (en) |
GB (1) | GB9022785D0 (en) |
IE (1) | IE913671A1 (en) |
LT (1) | LT3305B (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
EP0647137B1 (en) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycine receptor antagonists and the use thereof |
US5622965A (en) * | 1993-03-12 | 1997-04-22 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
EP0685466A1 (en) * | 1994-06-02 | 1995-12-06 | Ciba-Geigy Ag | 3-Heteroaliphatyle-and 3-hetero-(aryle)-aliphatyle-2(1H)-quinolone derivatives |
US5801168A (en) * | 1994-06-09 | 1998-09-01 | Zeneca Limited | Substituted nitrogen heterocycles |
FR2722786B1 (en) * | 1994-07-20 | 1996-08-23 | Rhone Poulenc Rorer Sa | DERIVATIVES OF 4-HYDROXY-3-PHENYL-INDENO (1,2-B) PYRIDINE-2 (1H) - ONE, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM |
DE4444815A1 (en) * | 1994-12-15 | 1996-06-20 | Merck Patent Gmbh | Thienopyridone |
US5773434A (en) * | 1995-08-30 | 1998-06-30 | Gary A. Rogers | Facilitation of AMPA receptor-mediated synaptic transmission in brain as a treatment for schizophrenia |
JP2943725B2 (en) | 1996-01-17 | 1999-08-30 | 大日本インキ化学工業株式会社 | Quinolinone derivatives and antiallergic agents containing the same as active ingredients |
DE19601782A1 (en) * | 1996-01-19 | 1997-07-24 | Merck Patent Gmbh | Quinoline-2- (1H) one |
GB9604400D0 (en) | 1996-03-01 | 1996-05-01 | Pfizer Ltd | Compounds useful in therapy |
DE69722613T2 (en) | 1996-05-15 | 2004-05-13 | Pfizer Inc. | 2,3,6-TRISUBSTITUTED 4 (3H) -QUINAZOLINONES |
US6147088A (en) * | 1996-05-20 | 2000-11-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
CA2254768A1 (en) * | 1996-05-20 | 1997-11-27 | Jinlong Jiang | Antagonists of gonadotropin releasing hormone |
JP2000511532A (en) * | 1996-05-20 | 2000-09-05 | メルク エンド カンパニー インコーポレーテッド | Gonadotropin-releasing hormone antagonists |
NZ336628A (en) * | 1997-02-28 | 2001-03-30 | Pfizer Prod Inc | Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists |
DE69809827D1 (en) * | 1997-03-31 | 2003-01-16 | Korea Res Inst Chem Tech | Quinolinic sulfide derivatives as NMDA receptor antagonists and process for their preparation |
US6962930B1 (en) | 1997-06-06 | 2005-11-08 | Lohocla Research Corporation | Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage |
DE69831446T2 (en) * | 1997-06-09 | 2006-06-14 | Pfizer Prod Inc | Quinazolin-4-one AMPA antagonists |
US6627755B1 (en) | 1997-06-09 | 2003-09-30 | Pfizer Inc | Quinazolin-4-one AMPA antagonists |
US5783700A (en) * | 1997-07-03 | 1998-07-21 | Nichols; Alfred C. | Quinolic acid derivatives |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
US6323208B1 (en) | 1997-09-05 | 2001-11-27 | Pfizer Inc | Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones |
WO2001039664A1 (en) * | 1999-12-02 | 2001-06-07 | The General Hospital Corporation | Method and apparatus for measuring indices of brain activity |
US6907280B2 (en) * | 1999-12-02 | 2005-06-14 | The General Hospital Corporation | Method and apparatus for objectively measuring pain, pain treatment and other related techniques |
EP1256341A4 (en) * | 2000-02-15 | 2004-12-08 | Teijin Ltd | Cancer remedy comprising anthranilic acid derivative as active ingredient |
US6602182B1 (en) | 2000-11-28 | 2003-08-05 | Abiomed, Inc. | Cardiac assistance systems having multiple fluid plenums |
GB0031315D0 (en) * | 2000-12-21 | 2001-02-07 | Glaxo Group Ltd | Indole derivatives |
DE10135466A1 (en) * | 2001-07-20 | 2003-02-06 | Bayer Cropscience Ag | Biphenyl-substituted 4-hydroxy-quinolones |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
GB0325175D0 (en) * | 2003-10-28 | 2003-12-03 | Novartis Ag | Organic compounds |
US7960548B2 (en) * | 2005-04-29 | 2011-06-14 | The Ohio State University Research Foundation | Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis |
AU2007210061A1 (en) * | 2006-01-30 | 2007-08-09 | Merck Sharp & Dohme Corp. | Inhibitors of fatty acid synthase (FAS) |
TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
CN110143918B (en) * | 2019-06-19 | 2020-08-04 | 青岛农业大学 | 3, 4-dihydro-3- (2-hydroxybenzoyl) -2(1H) -quinolinone active skeleton, synthetic method and application |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0093521B1 (en) * | 1982-05-04 | 1988-08-24 | Imperial Chemical Industries Plc | Quinoline derivatives |
EP0293146A1 (en) * | 1987-05-26 | 1988-11-30 | Kissei Pharmaceutical Co. Ltd. | Benzofuro [3,2-c] quinoline compounds |
JPH0696556B2 (en) | 1987-05-26 | 1994-11-30 | キッセイ薬品工業株式会社 | 2-quinolone derivative |
GB8719102D0 (en) * | 1987-08-12 | 1987-09-16 | Merck Sharp & Dohme | Therapeutic agents |
JPH01242585A (en) * | 1988-03-23 | 1989-09-27 | Kissei Pharmaceut Co Ltd | Production of benzofuro(3,2-c)quinoline derivative |
ES2074153T3 (en) * | 1989-09-26 | 1995-09-01 | Ciba Geigy Ag | PHOSPHONIC ACIDS, PROCEDURE FOR THEIR OBTAINING AND USE AS ACTIVE PRODUCTS FOR MEDICINES. |
US5039528A (en) * | 1989-12-11 | 1991-08-13 | Olney John W | EAA antagonists as anti-emetic drugs |
GB9022785D0 (en) * | 1990-10-19 | 1990-12-05 | Merck Sharp & Dohme | Therapeutic agents |
-
1990
- 1990-10-19 GB GB909022785A patent/GB9022785D0/en active Pending
-
1991
- 1991-10-10 AT AT91309309T patent/ATE148458T1/en not_active IP Right Cessation
- 1991-10-10 EP EP91309309A patent/EP0481676B1/en not_active Expired - Lifetime
- 1991-10-10 DE DE69124454T patent/DE69124454T2/en not_active Expired - Fee Related
- 1991-10-15 CA CA002053465A patent/CA2053465A1/en not_active Abandoned
- 1991-10-18 IE IE367191A patent/IE913671A1/en unknown
- 1991-10-18 JP JP3333890A patent/JPH0780853B2/en not_active Expired - Fee Related
-
1993
- 1993-04-19 LT LTIP491A patent/LT3305B/en not_active IP Right Cessation
- 1993-11-18 US US08/154,141 patent/US5348962A/en not_active Expired - Lifetime
-
1994
- 1994-07-11 US US08/273,525 patent/US5559125A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2053465A1 (en) | 1992-04-20 |
ATE148458T1 (en) | 1997-02-15 |
LT3305B (en) | 1995-06-26 |
EP0481676A1 (en) | 1992-04-22 |
GB9022785D0 (en) | 1990-12-05 |
US5559125A (en) | 1996-09-24 |
JPH05112531A (en) | 1993-05-07 |
JPH0780853B2 (en) | 1995-08-30 |
IE913671A1 (en) | 1992-04-22 |
DE69124454T2 (en) | 1997-08-07 |
EP0481676B1 (en) | 1997-01-29 |
DE69124454D1 (en) | 1997-03-13 |
US5348962A (en) | 1994-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTIP491A (en) | Hydroxyquinolone derivatives | |
WO1993011115A3 (en) | Quinolone derivatives and their use as nmda and ampa receptor antagonists | |
WO1993010783A3 (en) | Quinolone derivatives and their use as ampa and nmda receptor antagonists | |
ES2064520T3 (en) | DERIVATIVES OF BENZO HETERO-CYCLIC N-OXIDES (5,6) CYCLLOHEPTAPIRIDINAS, SUBSTITUTED, COMPOSITIONS AND METHODS OF USE. | |
WO2000066564A8 (en) | Benzimidazolones and analogues and their use as progesterone receptor ligands | |
EP0459561A3 (en) | Dioxo-tetrahydroquinoline derivatives | |
PT804419E (en) | QUINOLINE DERIVATIVES AS ANTAGONISTS OF THE TAQUIQUININ RECEPTOR NK3 | |
DE69127791T2 (en) | Diazabicyclononyl derivatives as 5-HT3 receptor antagonists | |
MA26837A1 (en) | HETEROALKY-LAMINO BICYCLIC NITROGEN HETEROCYCLES SUBSTITUTED AS P38 PROTEIN KINASE INHIBITORS. | |
CZ352196A3 (en) | Heterocyclic compounds exhibiting antagonistic activity on tachykinin receptor, their preparation and use | |
BG101715A (en) | Tetracyclic spiro compounds, process for their preparation and their use as 5ht 1 d receptor antagonists | |
DE69029668D1 (en) | Tetrahydroquinoline derivatives, useful for neurodegenerative diseases | |
ES2106825T3 (en) | PIPERIDINE DERIVATIVES. | |
KR920000724A (en) | 2,4- and 2, 5-substituted pyridine-N-oxides, preparation method thereof and use thereof | |
WO1992007832A3 (en) | Substituted piperazines as central nervous system agents | |
GB9325074D0 (en) | Bicyclic heterocycles | |
FR2722502B1 (en) | NOVEL BENZOTHIADIAZINE DERIVATIVE, ITS PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
ATE209036T1 (en) | USE OF IMIDAZO(A,5-A)QUINOLONES AS NEUROPROTECTIVE DRUGS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 19970419 |